Merck Panacur (fenbendazole) Paste
Panacur (fenbendazole) Paste 10% is indicated for the control of large strongyles (Strongylus edentatus, S. equinus, S. vulgaris), encysted early third stage (hypobiotic), late third stage and fourth stage cyathostome larvae, small strongyles, pinworms (Oxyuris equi), ascarids (Parascaris equorum) and arteritis caused by hypobiotic larvae of Strongylus vulgaris in horses.
Works on a wide variety of parasites ‐ Labeled for the control of large and small strongyles (including migrating larvae), pinworms and ascarids (roundworms)
Effective on encysted small strongyles ‐ A larvicidal dose is the only FDA-approved treatment for all stages of encysted small strongyles
Easy to administer ‐ A unique apple-cinnamon flavor that horses readily accept
Unique Mode of Action - The antiparasitic action of Panacur (fenbendazole) Paste 10% is due to the inhibition of energy metabolism in the parasite
Panacur (fenbendazole) Paste 10% is administered orally at a rate of 2.3 mg/lb (5 mg/kg) for the control of large strongyles, small strongyles, and pinworms. One 25 gram syringe will deworm a 1,100 lb horse. For foals and weanlings (less than 18 months of age) where ascarids are a common problem, the recommended dose is 4.6 mg/lb (10 mg/kg); one 25 gram syringe will deworm a 550 lb horse.
For control of encysted early third stage (hypobiotic), late third stage and fourth stage cyathostome larvae, and fourth stage larvae of Strongylus vulgaris, the recommended dose is 4.6 mg/lb (10 mg/kg) daily for 5 consecutive days; administer one 25 gram syringe for each 550 lbs body weight per day.
Consult your veterinarian for assistance in the diagnosis, treatment and control of parasitism.
Important Safety Information
Do not use in horses intended for human consumption. When using Panacur (fenbendazole) Paste 10% concomitantly with trichlorfon, refer to the manufacturer's labels for use and cautions for trichlorfon.